ADIM
FIAX icon

Alpha DNA Investment Management’s Nicholas Fixed Income Alternative ETF FIAX Stock Holding History

Alpha DNA Investment Management’s Portfolio FIAX Stock Details FIAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-15,133
Closed -$302K – 167
2022
Q4 		$302K Buy
+15,133
New +$302K 0.11% 144

Other funds holding FIAX

AWM
AE Wealth Management Topeka, Kansas $21.5B AUM 26.98% 1-Year Est. Return
SW
SMART Wealth Omaha, Nebraska $341M AUM 24.37% 1-Year Est. Return
BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
IFAM
Institutional & Family Asset Management Fort Collins, Colorado $654M AUM 12.29% 1-Year Est. Return

Alpha DNA Investment Management's FIAX Position: Q1 2023 in Review

Alpha DNA Investment Management sold out of Nicholas Fixed Income Alternative ETF (FIAX) in Q1 2023, closing a stake of 15,133 shares — an estimated $302K sold.

Alpha DNA Investment Management first reported a position in FIAX in Q4 2022 and held it in 1 quarter. The position peaked at $302K in Q4 2022. 7 funds tracked by Wall St. Rank hold FIAX as of Q1 2023.

  • Alpha DNA Investment Management reported no remaining Nicholas Fixed Income Alternative ETF position as of Q1 2023 after selling out during the quarter.
  • Alpha DNA Investment Management sold 15,133 Nicholas Fixed Income Alternative ETF shares in Q1 2023, an estimated $302K.
  • Alpha DNA Investment Management first reported a position in Nicholas Fixed Income Alternative ETF in Q4 2022 and held it in 1 quarter.
  • Alpha DNA Investment Management's Nicholas Fixed Income Alternative ETF position peaked at $302K in Q4 2022.
  • 7 funds tracked by Wall St. Rank held Nicholas Fixed Income Alternative ETF as of Q1 2023.

Based on Alpha DNA Investment Management's 13F filing for Q1 2023, filed 5 May 2023.